uniQure N.V (NASDAQ: QURE) is -15.81% lower on its value in year-to-date trading and has touched a low of $3.73 and a high of $11.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The QURE stock was last observed hovering at around $5.82 in the last trading session, with the day’s loss setting it -0.12%.
Currently trading at $5.70, the stock is -12.20% and -3.81% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.98 million and changing -2.06% at the moment leaves the stock -0.89% off its SMA200. QURE registered -18.16% loss for a year compared to 6-month gain of 13.10%. The firm has a 50-day simple moving average (SMA 50) of $5.9213 and a 200-day simple moving average (SMA200) of $5.75265.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.29% loss in the last 1 month and extending the period to 3 months gives it a -12.38%, and is -16.18% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.82% over the week and 8.57% over the month.
uniQure N.V (QURE) has around 480 employees, a market worth around $277.84M and $28.59M in sales. Profit margin for the company is -837.80%. Distance from 52-week low is 52.82% and -49.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-43.88%).
The EPS is expected to grow by 36.74% this year
163.0 institutions hold shares in uniQure N.V (QURE), with institutional investors hold 90.28% of the company’s shares. The shares outstanding are 47.83M, and float is at 42.67M with Short Float at 7.85%. Institutions hold 81.95% of the Float.
The top institutional shareholder in the company is VESTAL POINT CAPITAL, LP with over 4.75 million shares valued at $21.28 million. The investor’s holdings represent 9.8172 of the QURE Shares outstanding. As of 2024-06-30, the second largest holder is NANTAHALA CAPITAL MANAGEMENT, LLC with 2.65 million shares valued at $11.87 million to account for 5.4779 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 1.93 million shares representing 3.9801 and valued at over $8.63 million, while 683 CAPITAL MANAGEMENT, LLC holds 3.9269 of the shares totaling 1.9 million with a market value of $8.51 million.
uniQure N.V (QURE) Insider Activity
The most recent transaction is an insider sale by Abi-Saab Walid, the company’s Chief Medical Officer. SEC filings show that Abi-Saab Walid sold 1,447 shares of the company’s common stock on Jun 26 ’24 at a price of $4.36 per share for a total of $6309.0. Following the sale, the insider now owns 0.12 million shares.
uniQure N.V disclosed in a document filed with the SEC on Jun 17 ’24 that CALOZ PIERRE (Chief Operating Officer) sold a total of 2,936 shares of the company’s common stock. The trade occurred on Jun 17 ’24 and was made at $4.81 per share for $14122.0. Following the transaction, the insider now directly holds 0.12 million shares of the QURE stock.
Still, SEC filings show that on Jun 17 ’24, KLEMT CHRISTIAN (Chief Financial Officer) disposed off 1,611 shares at an average price of $4.80 for $7733.0. The insider now directly holds 164,837 shares of uniQure N.V (QURE).
